Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

You act as a paraphrase tool. Your role involves understanding the provided text…

  1. User

    System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :

    User: Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made within Note 13: Other Assets and Liabilities for the year ended December 31, 2022 to condense line items of the same nature into a single line. Concentrations of Risk. A significant portion of the Company’s cash, cash equivalents and marketable securities are held at two financial institutions. Due to their size, the Company believes these financial institutions represent minimal credit risk. The Company has not experienced any losses on its cash, cash equivalents, or marketable securities. The Company is subject to credit risk from its accounts receivable related to the sale of LUMRYZ. The Company extends credit to its customers, specialty pharmacies. Customer creditworthiness is monitored, and collateral is not required. Amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; Assistant:

  2. Assistant

    Positive: Whenever necessary, prior year amounts are adjusted to align with the current year's presentation. Within Note 13: Other Assets and Liabilities, certain reclassifications were made for the year ending December 31, 2022, to simplify line items with similar nature into a consolidated line. Risk Concentrations: A large share of the Company’s cash, cash equivalents, and marketable securities are stored at two financial institutions. Given their scale, the Company believes these financial institutions pose minimal credit risk. The Company has not faced any losses regarding its cash, cash equivalents, or marketable securities. The Company faces credit risk pertaining to accounts receivable from LUMRYZ sales. Credit is extended to customers, which are specialty pharmacies, and their creditworthiness is continuously assessed without requiring collateral. Amounts receivable are shown net of an allowance that includes an expected credit losses evaluation. An allowance for credit losses is set up based on anticipated losses, and these losses are estimated by examining individual accounts, considering factors such as aging, debtor's financial health, payment history, current economic conditions as well as forecasts, and additional relevant aspects. If the Company finds that any customer's credit quality has worsened, it sets allowances based on that customer's unique risk characteristics. The Company diligently works to recover all balances outstanding from customers.

    Negative: Previous year amounts are never adjusted to match the presentation of the current year. For the year ending December 31, 2022, no reclassifications were necessary within Note 13: Other Assets and Liabilities, thus maintaining multiple items of the same nature as separate entries. Risk Concentrations: Only a minor portion of the Company’s cash, cash equivalents, and investments are kept at two financial institutions. Due to their size, the Company believes these financial institutions are major credit risks. The Company has encountered losses on its cash, cash equivalents, or marketable securities. The Company is free from credit risk associated with accounts receivable from LUMRYZ sales. The Company refrains from extending any credit to its customers. Customer creditworthiness is not monitored, and collateral is frequently required. Amounts owed to the Company are displayed without any allowance, and there is no assessment of expected credit losses. No allowance for credit losses is necessary because losses aren't expected. Expected losses are determined without reviewing individual accounts or considering economic conditions. If any individual customer's credit becomes questionable, the Company sees no need to establish custom allowances based on distinct risk characteristics. The Company is unconcerned with collecting outstanding balances from its customers.